Academia.edu no longer supports Internet Explorer.
To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.
2013, Annals of the Rheumatic Diseases
Clinical Drug Investigation
Short-Term Efficacy and Safety of Leflunomide in the Treatment of Active Rheumatoid Arthritis in Everyday Clinical Use2012 •
Revista Brasileira de Reumatologia
Eficácia terapêutica e segurança de metotrexato + leflunomida em pacientes colombianos com artrite reumatoide ativa refratária ao tratamento convencional2012 •
British Journal of Clinical Pharmacology
Leflunomide in active rheumatoid arthritis: a prospective study in daily practice2004 •
The Journal of Rheumatology
Adverse events with disease modifying antirheumatic drugs (DMARD): a cohort study of leflunomide compared with other DMARDTo determine and compare the incidence of serious adverse events (AE) during treatment of rheumatoid arthritis (RA) with disease modifying antirheumatic drugs (DMARD), focusing on leflunomide (LEF). A retrospective cohort study of a large US insurance claims database was performed. Study groups were patients with RA classified by DMARD exposure as either no-DMARD therapy, single-agent DMARD (monotherapy), or combination-DMARD therapy. Specific DMARD examined were leflunomide (LEF) and methotrexate (MTX), compared to other DMARD (penicillamine, hydroxychloroquine, sulfasalazine, gold, etanercept, infliximab) and no DMARD (nonsteroidal antiinflammatory drugs, COX-2 inhibitors). All AE reported were considered endpoints; primary endpoints included hepatic, dermatologic, hematologic, infectious, respiratory, hypertension, and pancreatitis AE. The 40,594 RA patients of the study period (September 1998 to December 2000) accumulated 83,143 person-years (PY) of followup. Followup for each o...
Revista Brasileira de Reumatologia
Toxicidade hepática é rara em pacientes com artrite reumatoide usando terapia combinada de leflunomida e metotrexato2011 •
Arthritis and Rheumatism
Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate2001 •
Advances in Clinical and Experimental Medicine
The efficacy and safety of leflunomide in patients with active rheumatoid arthritisThe aim of this study was to evaluate the efficacy and safety of leflunomide in patients with active rheumatoid arthritis (RA). The study included 100 patients (88 women and 12 men) with rheumatoid arthritis (RA). The mean age was 46.5 years and the mean duration of the disease was 10.3 years. The inclusion criteria were a Disease Activity Score (DAS28) of over 3.2, and contraindications to methotrexate or failure of treatment with methotrexate for at least 3 months. The patients that were enrolled in the study had developed lesions of various grades according to the Steinbrocker Radiological Classification. Leflunomide was administered at a dose of 20 mg per day for the whole observation period. During the monitoring appointments the duration of morning stiffness, pain and disease activity were evaluated on a visual analogue scale (VAS), as well as the number of tender and swollen joints and the DAS28 score. In compliance with the leflunomide therapy protocol, the following control...
Worldwide, the gender gap in urban cycling is considerable, with most cyclists being young to middle-aged men. In the current study, we first capture the suite of cycling barriers facing women before empirically investigating whether and how much three natural barriers (inclement weather, hilliness, and darkness) impact female users of bikesharing systems. For the analysis, we spatially integrate gender for more than 200 million bikesharing trips with fine-grained weather, gradient, and sunset/sunrise data. Computing a suite of the generalized additive models for ten cities worldwide covering a period of 14 years, we find that wind and precipitation disincentivise cycling, and more so for women than for men. Similarly, steeper gradients are a significant barrier for female bikeshare users for many cities. In every city, women make fewer trips in the dark (i.e., before sunrise and after sunset) compared to men. In higher-cycling cities, regardless of natural barriers, cycling declines less with age for women compared to other cities. To overcome the barriers presented by inclement weather, hilliness, and darkness we recommend (a) partial electrification of bikesharing fleets, (b) reduced exposure along bicycle paths (through manufactured shelters or tree canopies), and (c) adequate nighttime lighting along cycling paths. In the spirit of open science, all data and code on which this paper is based have been provided on Mendeley: https://data.me ndeley.com/datasets/vmy42hywwx/1.
2017 •
Journal of Wildlife Diseases
Epizootic Vesicular Stomatitis in Colorado, 1982: Some Observations on the Possible Role of Wildlife Populations in an Enzootic Maintenance Cycle1987 •
Chemical & Pharmaceutical Bulletin
Inhibition of Cytopathic Effect of Human Immunodeficiency Virus Type-1 by Various Phorbol Derivatives2002 •
Journal of Cultural Heritage Management and Sustainable Development
A value-based monitoring system to support heritage conservation planning2013 •
Journal of Sustainable Development
Green Worship House Competition as an Effective Tool to Evaluate Green Pyramid Rating System (GPRS)2019 •
Food Chemistry
Chemical composition, antimicrobial, cytotoxic and antioxidant activities of the essential oil of Artemisia indica Willd2013 •
Europe's journal of psychology
The Mediating Role of Perceived Social Support in the Relationships Between General Causality Orientations and Locus of Control With Psychopathological Symptoms2018 •
HAL (Le Centre pour la Communication Scientifique Directe)
Le concept de traditionalité des produits alimentaires2018 •